Callan Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.51M Buy
9,090
+2,122
+30% +$332K 0.11% 89
2024
Q4
$1.01M Sell
6,968
-1,190
-15% -$184K 0.07% 107
2024
Q3
$1.32M Buy
8,158
+1,770
+28% +$282K 0.09% 100
2024
Q2
$934K Buy
6,388
+740
+13% +$110K 0.08% 112
2024
Q1
$893K Buy
5,648
+1,290
+30% +$205K 0.08% 106
2023
Q4
$683K Buy
4,358
+404
+10% +$61.9K 0.06% 112
2023
Q3
$616K Buy
3,954
+305
+8% +$50.3K 0.07% 105
2023
Q2
$604K Sell
3,649
-539
-13% -$87K 0.07% 99
2023
Q1
$649K Sell
4,188
-1,563
-27% -$252K 0.08% 92
2022
Q4
$1.02M Buy
5,751
+1,711
+42% +$295K 0.13% 76
2022
Q3
$660K Buy
4,040
+2,774
+219% +$469K 0.11% 75
2022
Q2
$225K Sell
1,266
-44
-3% -$7.84K 0.03% 106
2022
Q1
$232K Sell
1,310
-432
-25% -$73.5K 0.03% 109
2021
Q4
$298K Buy
+1,742
New +$285K 0.04% 108
2021
Q3
Sell
-1,521
Closed -$251K 88
2021
Q2
$251K Buy
+1,521
New +$252K 0.04% 80

Other funds holding JNJ

Callan Capital's JNJ Position: Q1 2025 in Review

Callan Capital increased its Johnson & Johnson (JNJ) stake by 30% in Q1 2025, buying an estimated $332K and bringing the position to 9,090 shares worth $1.51M. The position accounts for 0.11% of the portfolio, ranked #89.

Callan Capital first reported a position in JNJ in Q2 2021 and has held it in 15 quarters since. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Callan Capital held 9,090 shares of Johnson & Johnson worth $1.51M as of Q1 2025.
  • Callan Capital bought 2,122 Johnson & Johnson shares in Q1 2025, an estimated $332K.
  • Johnson & Johnson made up 0.11% of Callan Capital's portfolio in Q1 2025, its #89 holding.
  • Callan Capital first reported a position in Johnson & Johnson in Q2 2021 and has held it in 15 quarters since.
  • 4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.